Ultimate magazine theme for WordPress.

US IPO Weekly Review: Reinsurance and CAR-T Therapies Lead a 3-IPO Week

Brilliant buddy

Three IPOs and two SPACs debuted this week as the pipeline got a boost from a flurry of initial filings.

Oncology Biotechnology CARGO Therapeutics (CRGX) is at the lower end of the range, raising $281 million

5 IPOs in the week of November 6, 2023
IssuerBusiness DealSize IPO by market capitalization Price vs. mean First day of return On November 10th returned
AI Transportation Acq. (AITRU) $60 million $79 million 0% +2% +2%
Blank check company targeting the AI ​​transportation industry.
Ag & Nat Solutions Acq. (ANSCU) $300 million $375 million 0% +1% +1%
Blank check company backed by Riverstone and Impact Ag focused on decarbonization in agriculture.
Hamilton Group (HG) $225 million $1,696 million -12% +0% +0%
Reinsurance and specialty insurance provider based in Bermuda.
CARGO Therapeutics (CRGX) $281 million $611 million -6% -3% -3%
Phase 2 biotech is developing CAR T-cell therapies for hematological cancers.
Globavend (GVH) $6 million $59 million -11% -36% -53%
Provides cross-border logistics and shipping services.

click to enlarge

8 submissions in the week of November 6, 2023
IssuerBusiness DealSize sector Lead Underwriter
QMIS TBS Capital Group (QMIX) $17 million Industry Pacific Century Securities
Malaysia-based consulting and software development services provider.
ZEEKR (ZK) $500 million Consumer Discretionary Goldman
The premium electric vehicle brand emerged from the Chinese car manufacturer Geely.
Fortegra ((TFG)) $100 million Finance Goldman
Specialist insurer with a focus on niche lines of business and fee-based services.
HW Electro (HWEP) $17 million Consumer Discretionary Univest Sec.
Japanese electric light commercial vehicle retailer.
Sichuan WB Technology (WMBT) $70 million SPAC
Blank check company for businesses in China and APAC.
Amphitrite Digital (AMDI) $10 million Consumer Discretionary Maxim
Offers maritime tours and activities in the mainland United States and the U.S. Virgin Islands.
FibroBiologics (FBLG) $0 million Healthcare
Phase 1 biotechnology developing fibroblast-based therapies for chronic diseases.
Sequoia vaccines (SQVI) $20 million Healthcare ThinkEquity
Phase 1 biotech is developing a vaccine against recurrent urinary tract infections and small molecules against cancer.

click to enlarge

US IPO calendar
IssuerBusiness Deal SizeMarket Cap Price range shares filed TopBookrunners
Signing Day Sports (SGN) Scottsdale, AZ $8 million $58 million 4 to $61,500,000 Boustead
Operates a recruiting platform for student-athletes.
DDC Enterprise (DDC) Hong Kong, China $45 million $226 million $9.50 – $11,504,250,000 CMBIBenchmark
Sells prepared foods and operates a recipe-sharing platform in China.
Shimmick (SHIM) Irvine, CA $50 million $333 million $10 to $124,550,000 Roth cap.
California-based construction company specializing in public water infrastructure.

click to enlarge

Comments are closed.

%d bloggers like this: